FIELD: biotechnology.
SUBSTANCE: invention relates to method for heterological expression of Neisseria meningitidis protein in E. coli. Expressed protein has immunogenic activity in relation to Neisseria meningitidis.
EFFECT: immunogenic proteins of high effectiveness.
9 cl, 26 dwg, 1 tbl, 23 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HETEROLOGOUS EXPRESSION OF NEISSERIA PROTEINS | 2001 |
|
RU2299906C2 |
| HYBRID AND TANDEM EXPRESSION OF NEISSERIAL PROTEINS | 2002 |
|
RU2475495C2 |
| COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF INFECTION CAUSED BY MICROORGANISM NEISSERIA | 2000 |
|
RU2244749C2 |
| HYBRID AND TANDEM EXPRESSION OF NEISSERIA PROTEINS | 2002 |
|
RU2339646C2 |
| COMPOSITIONS OF MENINGOCOCCAL VACCINES WITH ADJUVANTS | 2002 |
|
RU2360699C2 |
| LIQUID VACCINE FOR MULTIPLE SEROGROUPS OF MENINGOCOCCUS | 2009 |
|
RU2595845C2 |
| POLYPEPTIDE VACCINES FOR WIDE PROTECTION AGAINST ROWS OF MENINGOCOCCUS GENERATIONS WITH INCREASED VIRULENCE | 2003 |
|
RU2333007C2 |
| LIQUID VACCINES FOR MULTIPLE MENINGOCOCCAL SEROGROUPS | 2004 |
|
RU2378010C2 |
| OUTER MEMBRANE VESICLE VACCINE (OMV) CONTAINING PROTEINS OF SEROGROUP B N.Meningitis OUTER MEMBRANE | 2001 |
|
RU2279889C2 |
| ANTIGENES NEISSERIA MENINGITIDIS | 1999 |
|
RU2343159C2 |
